Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

5.5K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

1.7K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.7K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

751
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
751
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Anabolic-Androgenic Steroid Abuse on the Cardiovascular System: Molecular Mechanisms and Clinical Implications.

International journal of molecular sciences·2025
Same author

Preoperative Albumin-Bilirubin (ALBI) Score Is the Strongest Predictor of Mortality After LVAD Implantation.

Biomedicines·2025
Same author

Copeptin, Routine Laboratory Parameters, and Ischemic Etiology of Heart Failure Predict Outcomes in Elderly Patients with Decompensated Heart Failure.

Biomedicines·2025
Same author

Model for End-Stage Liver Disease Excluding INR Is Associated with Poor Prognosis in Elderly Patients with Decompensated Heart Failure.

Biomedicines·2025
Same author

Albumin-Bilirubin (ALBI) Score Predicts Long-Term Survival in Elderly Patients with Decompensated Heart Failure.

Journal of clinical medicine·2025
Same author

Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers.

Pharmaceuticals (Basel, Switzerland)·2025

Related Experiment Video

Updated: Apr 25, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.1K

Cardiovascular Safety of Hormonal Contraception: Method-Specific Risks and Clinical Implications.

Iga Waluszewska1, Antoni Borowiec1, Alicja Paciorek1

  • 1Students' Scientific Society, Department of Pharmacology, Faculty of Medicine, University of Opole, 45-052 Opole, Poland.

Medical Sciences (Basel, Switzerland)
|April 24, 2026
PubMed
Summary

Hormonal contraceptives, while effective for pregnancy prevention, carry cardiovascular risks like venous thromboembolism (VTE). Estrogen-free options are safer for women with contraindications, offering a preferred choice.

Keywords:
cardiovascular riskhormonal contraceptionischemic strokemyocardial infarctionprothrombotic risk factorsrisk stratificationthromboembolism

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Related Experiment Videos

Last Updated: Apr 25, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.1K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Area of Science:

  • Reproductive Health
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hormonal contraception is a widely used reversible method for pregnancy prevention.
  • Cardiovascular (CV) safety is a key consideration, with risks including venous thromboembolism (VTE), stroke, myocardial infarction, and hypertension.
  • Estrogen-containing combined hormonal contraceptives (CHCs) are associated with an increased VTE risk, though absolute rates are low in healthy, young, non-smoking individuals.

Purpose of the Study:

  • To review current evidence on method-specific CV risks associated with hormonal contraception.
  • To elucidate the mechanisms underlying these CV effects.
  • To offer practical guidance for clinical decision-making regarding hormonal contraceptive use.

Main Methods:

  • Systematic review of current scientific literature.
  • Analysis of epidemiological data on cardiovascular events.
  • Evaluation of pharmacological mechanisms influencing cardiovascular risk.

Main Results:

  • Combined hormonal contraceptives (CHCs) increase VTE risk, influenced by estrogen dose, progestin type, and administration route.
  • Individual factors like age, smoking, migraines with aura, hypertension, obesity, thrombophilia, and certain medications significantly modify risk.
  • Progestin-only contraceptives and LNG-IUSs demonstrate a more favorable thrombotic profile.

Conclusions:

  • Hormonal contraception necessitates careful CV risk assessment.
  • Progestin-only methods and LNG-IUSs are preferable for individuals with contraindications to estrogen.
  • Personalized risk-benefit analysis is crucial for safe and effective contraceptive choice.